Loading...

RANI RANI THERAPEUTICS HOLDINGS INC Delisting Actions 8-K Filing

RN T

RN

RANI THERAPEUTICS HOLDINGS INC

(RANI)

2025 8-K

Financial Update

Governance Changes

Financial Update

Major Financing Event

Financial Statements

Equity Offerings

Notification of Non-Compliance

Financial Statements

Nasdaq Compliance

Financial Results

Financial Results

Securities Offering

Earnings Reports

Securities Purchase Agreement

Equity Financing Decision

Collaboration Agreement

Annual Meeting of Stockholders

Financial Results Announcement

Earnings Reports

Clinical Trial Results

Stock Option Repricing

Preclinical Data and Clinic...

Earnings Reports

Lease Agreement and Restruc...

Preclinical Data Announcement

Drug Delivery Results

Financial Results Announcement

License and Supply Agreement

Earnings Reports

Departure of Directors

Results of Operations and F...

License and Supply Agreement

Financial Condition

External Links:

On June 20, 2025, Rani Therapeutics received a notice from Nasdaq stating that its stock price has fallen below the required $1 minimum bid for the past 30 days, leading to potential delisting unless compliance is restored by December 17, 2025.

AI Assistant

RANI THERAPEUTICS HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.